CLINICAL_TRIALS
trial_result
· 2014-08-29
Clinical Trial Update: Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036) [Phase 1]
Summary
Phase 1 trial update on suvorexant (MK-4305-036) in participants with sleep apnea; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Sleep Apnea | Phase 1 | Status: COMPLETED | Results posted: 2014-08-29